Background and purpose Our objective was to evaluate the extent to which the 2005
recommendations of the European Federation of Neurological Sciences (EFNS) on the …

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder characterised by
loss of motor neurons. The cause of disease is unknown other than in the rare cases of …

Amyotrophic Lateral Sclerosis is a neurodegenerative disease caused by progressive loss
of motor neurons, which severely compromises skeletal muscle function. Evidence shows …

Amyotrophic lateral sclerosis (ALS) or Lou Gehrig's disease is the most common motor
neuron disease in human adults, described as early as 1869 by a French neurobiologist and …

with bulbar onset, 35% of placebo-treated patients were still alive compared with 73% of
riluzoletreated patients; whereas for the limb-onset patients, 64% of placebo-treated patients …

BackgroundAmyotrophic lateral sclerosis (ALS) is a progressive disease with no effective
treatment. In an initial study, riluzole decreased mortality and slowed muscle-strength …

Amyotrophic lateral sclerosis (ALS) is the most common adult-onset motor neuron disease.
ALS is a progressive neurodegenerative disorder, involving motor neurons in the cerebral …

Riluzole is to date the only treatment that prolongs amyotrophic lateral sclerosis (ALS)
survival. However, results on the efficacy of riluzole in observational population‐based …

ALS is a lethal neurodegenerative disease wherein the diagnosis is often delayed. Our
understanding of the pathobiology is slowly expanding, and the number of new genes is …